Serum CXCL6 was higher in ANCA-associated vasculitis with interstitial lung disease and independently predicted ILD ...

Please provide your email address to receive an email when new articles are posted on . Eight clusters of related biomarkers were significantly associated with RA-ILD. The biomarkers led to a greater ...

The FDA has expanded the approval of Jascayd (nerandomilast), an oral phosphodiesterase 4 (PDE4) inhibitor, to include treatment of progressive pulmonary fibrosis in adults.

“Following the initial pause, the FDA has placed the trial on a partial clinical hold,” the spokesperson explained.

Adding pirfenidone to mycophenolate mofetil shows no significant improvement in lung function compared with mycophenolate ...

Enhertu showed improved iDFS over Kadcyla in early-stage HER2-positive breast cancer with residual disease post-neoadjuvant ...

The prevalence of interstitial lung disease (ILD) across connective tissue disorders (CTDs) and its persistent standing as a leading cause of death in patients with CTDs challenge rheumatologists to ...

Please provide your email address to receive an email when new articles are posted on . Newly announced ACR guidelines recommend against glucocorticoids as first-line therapy for interstitial lung ...

Lung ultrasound is effective for detecting ILD in RA patients, with high sensitivity and moderate specificity. B-lines are a primary criterion for ILD diagnosis in LUS, indicating pulmonary ...

Serac Healthcare, a clinical radiopharmaceutical company, and the University of Exeter have announced the commencement of a Phase II study involving a novel molecular SPECT imaging agent, ...

Have you heard of Interstitial Lung Disease (ILD)? Like most people, you may not have – ILDs are, after all, a group of lung disorders that are significantly rare compared to other pulmonary diseases.

Achieving equitable access to anti-fibrotic drugs requires multi-stakeholder collaboration, while the most critical unmet ...